<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:53:55Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8076764" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8076764</identifier>
        <datestamp>2021-04-27</datestamp>
        <setSpec>pheelsevier</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3-mathml3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Epidemics</journal-id>
              <journal-id journal-id-type="iso-abbrev">Epidemics</journal-id>
              <journal-title-group>
                <journal-title>Epidemics</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1755-4365</issn>
              <issn pub-type="epub">1878-0067</issn>
              <publisher>
                <publisher-name>The Authors. Published by Elsevier B.V.</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8076764</article-id>
              <article-id pub-id-type="pmcid">PMC8076764</article-id>
              <article-id pub-id-type="pmc-uid">8076764</article-id>
              <article-id pub-id-type="pmid">34015676</article-id>
              <article-id pub-id-type="pii">S1755-4365(21)00018-9</article-id>
              <article-id pub-id-type="doi">10.1016/j.epidem.2021.100459</article-id>
              <article-id pub-id-type="publisher-id">100459</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Memory is key in capturing COVID-19 epidemiological dynamics</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" id="au000001">
                  <name>
                    <surname>Sofonea</surname>
                    <given-names>Mircea T.</given-names>
                  </name>
                  <xref rid="cor1" ref-type="corresp">⁎</xref>
                </contrib>
                <contrib contrib-type="author" id="au000002">
                  <name>
                    <surname>Reyné</surname>
                    <given-names>Bastien</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="author" id="au000003">
                  <name>
                    <surname>Elie</surname>
                    <given-names>Baptiste</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="author" id="au000004">
                  <name>
                    <surname>Djidjou-Demasse</surname>
                    <given-names>Ramsès</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="author" id="au000005">
                  <name>
                    <surname>Selinger</surname>
                    <given-names>Christian</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="author" id="au000006">
                  <name>
                    <surname>Michalakis</surname>
                    <given-names>Yannis</given-names>
                  </name>
                </contrib>
                <contrib contrib-type="author" id="au000007">
                  <name>
                    <surname>Alizon</surname>
                    <given-names>Samuel</given-names>
                  </name>
                </contrib>
                <aff id="aff1">MIVEGEC, Univ. Montpellier, CNRS, IRD, France</aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>⁎</label>Corresponding author.</corresp>
              </author-notes>
              <pub-date pub-type="pmc-release">
                <day>27</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
              <pub-date pub-type="ppub">
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>27</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <volume>35</volume>
              <fpage>100459</fpage>
              <lpage>100459</lpage>
              <history>
                <date date-type="received">
                  <day>27</day>
                  <month>7</month>
                  <year>2020</year>
                </date>
                <date date-type="rev-recd">
                  <day>21</day>
                  <month>3</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>23</day>
                  <month>3</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 The Authors</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license>
                  <license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
                </license>
              </permissions>
              <abstract id="d1e280">
                <p>SARS-CoV-2 virus has spread over the world rapidly creating one of the largest pandemics ever. The absence of immunity, presymptomatic transmission, and the relatively high level of virulence of the COVID-19 infection led to a massive flow of patients in intensive care units (ICU). This unprecedented situation calls for rapid and accurate mathematical models to best inform public health policies.</p>
                <p>We develop an original parsimonious discrete-time model that accounts for the effect of the age of infection on the natural history of the disease. Analysing the ongoing COVID-19 in France as a test case, through the publicly available time series of nationwide hospital mortality and ICU activity, we estimate the value of the key epidemiological parameters and the impact of lock-down implementation delay.</p>
                <p>This work shows that including memory-effects in the modelling of COVID-19 spreading greatly improves the accuracy of the fit to the epidemiological data. We estimate that the epidemic wave in France started on Jan 20 [Jan 12, Jan 28] (95% likelihood interval) with a reproduction number initially equal to 2.99 [2.59, 3.39], which was reduced by the national lock-down started on Mar 17 to 24 [21, 27] of its value. We also estimate that the implementation of the latter a week earlier or later would have lead to a difference of about respectively <inline-formula><mml:math id="d1e291" display="inline" altimg="si1.svg"><mml:mo>−</mml:mo></mml:math></inline-formula>13k and <inline-formula><mml:math id="d1e296" display="inline" altimg="si2.svg"><mml:mo>+</mml:mo></mml:math></inline-formula>50k hospital deaths by the end of lock-down.</p>
                <p>The present parsimonious discrete-time framework constitutes a useful tool for now- and forecasting simultaneously community incidence and ICU capacity strain.</p>
              </abstract>
              <kwd-group id="d1e329">
                <title>Keywords</title>
                <kwd>Mathematical epidemiology</kwd>
                <kwd>Discrete-time modelling</kwd>
                <kwd>Non-Markovian processes</kwd>
                <kwd>Epidemiosurveillance</kwd>
                <kwd>Reproduction number</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec1">
              <label>1</label>
              <title>Introduction</title>
              <p id="d1e354">In Dec 2019, an increasing number of ‘pneumonia of unknown etiology’ cases were reported in Wuhan, China (<xref rid="b22" ref-type="bibr">Li et al., 2020a</xref>). The causal agent was rapidly identified as a new coronavirus named SARS-Cov-2 (<xref rid="b5" ref-type="bibr">Coronaviridae Study Group of the ICTV, 2020</xref>). Because of its relatively large basic reproduction number (<inline-formula><mml:math id="d1e369" display="inline" altimg="si3.svg"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="script">R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">≈</mml:mo><mml:mn>2</mml:mn><mml:mo>.</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:math></inline-formula> in the Wuhan outbreak (<xref rid="b22" ref-type="bibr">Li et al., 2020a</xref>)) and the high proportion of undetected cases (<xref rid="b26" ref-type="bibr">Nishiura et al., 2020</xref>, <xref rid="b23" ref-type="bibr">Li et al., 2020b</xref>, <xref rid="b16" ref-type="bibr">He et al., 2020</xref>), the virus rapidly spread in mainland China and then all over the world. The sizeable virulence of the so-called COVID-19 infection – the fatality ratio of which was estimated to approx. 1% in China (<xref rid="b33" ref-type="bibr">Verity et al., 2020</xref>) – and the important proportion of severe cases requiring hospitalisation rapidly made it the primary health concern worldwide.</p>
              <p id="d1e403">The COVID-19 pandemic provides an opportunity to develop adequate tools for the short-term forecasting and potential management of this and future epidemics. In the absence of any prophylactic or curative pharmaceutical solution, the nations and their healthcare systems face two major challenges. The first one is blocking the transmission chains in the community with measures such as social distancing, school closure, mask-wearing, tracking and quarantine, along with massive testing (<xref rid="b12" ref-type="bibr">Flaxman et al., 2020</xref>). The second one is caring for the hospitalised patients with severe complications, especially within intensive care units (ICU) (<xref rid="b4" ref-type="bibr">Bouadma et al., 2020</xref>).</p>
              <p id="d1e415">At the early stage of the epidemic, and until a very restrictive non-pharmaceutical intervention (NPI) such as national lock-down is implemented, the incidence is growing exponentially. Consequently, both the means of prevention (mask stocks, PCR reagents, tracking logistics) and the ICU bed capacity can be rapidly overloaded, exposing health systems to a major crisis. The optimal allocation of these limited resources over time is therefore crucial (<xref rid="b15" ref-type="bibr">Halpern, 2011</xref>, <xref rid="b8" ref-type="bibr">Djidjou-Demasse et al., 2020</xref>) and require models to predict short-term dynamics as accurately as possible (<xref rid="b34" ref-type="bibr">Weissman et al., 2020</xref>).</p>
              <p id="d1e427">The vast majority of epidemiological models relies on ordinary differential equations (ODEs) (<xref rid="b20" ref-type="bibr">Keeling and Rohani, 2008</xref>). Although these models have useful analytical properties when analysed over a long time period, they perform poorly on short time scales. One reason for this is that they are essentially Markovian, i.e. ‘memoryless’. This means for instance that an individual that has been infected for 10 days has the same probability to clear the infection as e.g. an individual infected less than a day ago.</p>
              <p id="d1e434">
In this work, we develop an original discrete-time method that combines the advantages of individual-based approaches and the law of large numbers, to best analyse ICU activity and hospital mortality time series, both being particularly informative because of their high and homogeneous sampling rate (i.e. few cases are missed). This is done by introducing a parsimonious model supported by an original statistical treatment that best reproduces chronologically the natural history of disease. Using the French epidemics as a test case we show that, contrary to its memory-less counterpart, the model can very accurately capture the ICU admission, occupancy, and mortality peaks. It can thus be used to forecast epidemics and evaluate potential disease control implementations.<fig id="fig1"><label>Fig. 1</label><caption><p><bold>COVID-19 epidemic discrete-time model structure.</bold> Each square represents a group of individuals who share the same clinical kinetics and who contribute equally to the epidemic dynamics. Contiguous squares form a day after day progression sequence which captures the memory effects of the infection age. Pink boxes correspond to infected individuals in the community (yellow area). Light blue boxes represent critical cases cared for in hospitals (blue area). The grey area corresponds to removed compartments that do not contribute to the epidemic. Arrows between boxes correspond to the daily flow of individuals. Dotted arrows depict transitions that occur with probability <inline-formula><mml:math id="d1e30" display="inline" altimg="si4.svg"><mml:mn>1</mml:mn></mml:math></inline-formula>. For the sake of simplicity, only one age group <inline-formula><mml:math id="d1e35" display="inline" altimg="si5.svg"><mml:mi>i</mml:mi></mml:math></inline-formula> is here depicted and only one of the two probabilities is shown for each bifurcating transition. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p></caption><graphic xlink:href="gr1_lrg"/></fig></p>
            </sec>
            <sec id="sec2">
              <label>2</label>
              <title>Methods</title>
              <sec id="sec2.1">
                <label>2.1</label>
                <title>Model structure and dynamics</title>
                <p id="d1e448">As classically done (<xref rid="b21" ref-type="bibr">Kermack and McKendrick, 1927</xref>, <xref rid="b20" ref-type="bibr">Keeling and Rohani, 2008</xref>), we group individuals with the same epidemiological contribution into compartments whose densities are tracked over time. Given that many COVID-19 clinical outcome proportions are age-dependent – e.g. the infection fatality ratio (IFR) (<xref rid="b33" ref-type="bibr">Verity et al., 2020</xref>) – we further split each compartment into an arbitrary number of age groups, denoted by index <inline-formula><mml:math id="d1e461" display="inline" altimg="si5.svg"><mml:mi>i</mml:mi></mml:math></inline-formula>. This allows us to adjust nationwide averages and capture demographic effects by matching demography to age-stratified hospital data.</p>
                <p id="d1e465">The structure of the system is shown in <xref rid="fig1" ref-type="fig">Fig. 1</xref>. Initially, all individuals in group <inline-formula><mml:math id="d1e472" display="inline" altimg="si5.svg"><mml:mi>i</mml:mi></mml:math></inline-formula> belong to the susceptible compartment, the density of which is denoted <inline-formula><mml:math id="d1e477" display="inline" altimg="si8.svg"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. These individuals can be infected with a daily probability called the force of infection, the expression of which is <disp-formula id="fd1"><label>(1)</label><mml:math id="d1e494" display="block" altimg="si9.svg"><mml:mrow><mml:msub><mml:mrow><mml:mi>Λ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:msup><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">+</mml:mo><mml:msup><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="script">R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:munder class="underset"><mml:mrow><mml:mo linebreak="badbreak">∑</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:munder><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:munder class="underset"><mml:mrow><mml:mo linebreak="badbreak">∑</mml:mo></mml:mrow><mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:munder><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mo linebreak="badbreak">−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mo linebreak="badbreak">−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="d1e628" display="inline" altimg="si10.svg"><mml:msub><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>τ</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the prevalence of <inline-formula><mml:math id="d1e642" display="inline" altimg="si11.svg"><mml:mi>j</mml:mi></mml:math></inline-formula>-individuals infected since <inline-formula><mml:math id="d1e647" display="inline" altimg="si12.svg"><mml:mi>τ</mml:mi></mml:math></inline-formula> days, <inline-formula><mml:math id="d1e653" display="inline" altimg="si13.svg"><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> the <italic>per capita</italic> contact rate and <inline-formula><mml:math id="d1e666" display="inline" altimg="si14.svg"><mml:msub><mml:mrow><mml:mi>ζ</mml:mi></mml:mrow><mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> the discretised serial interval distribution, i.e. the relative contribution of each day upon infection to the individual force of infection (see Appendix S2.2 for the derivation).</p>
                <p id="d1e675">Upon infection, a fraction <inline-formula><mml:math id="d1e678" display="inline" altimg="si15.svg"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:msub><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> of the individuals will develop non-critical infections and move to the <inline-formula><mml:math id="d1e693" display="inline" altimg="si16.svg"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>⋅</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> compartment, where the second subscript indicates the age of the infection (in days). At each time step, an individual in the compartment <inline-formula><mml:math id="d1e707" display="inline" altimg="si17.svg"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> moves to the compartment <inline-formula><mml:math id="d1e722" display="inline" altimg="si18.svg"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and after <inline-formula><mml:math id="d1e740" display="inline" altimg="si19.svg"><mml:mi>g</mml:mi></mml:math></inline-formula> days of infection it moves to the recovered (and assumed lastingly immunised) compartment <inline-formula><mml:math id="d1e745" display="inline" altimg="si20.svg"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>.</p>
                <p id="d1e754">A fraction <inline-formula><mml:math id="d1e757" display="inline" altimg="si21.svg"><mml:msub><mml:mrow><mml:mi>θ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> of infections will lead to critical complications (typically acute respiratory distress syndrome (<xref rid="b4" ref-type="bibr">Bouadma et al., 2020</xref>)), and move to the <inline-formula><mml:math id="d1e772" display="inline" altimg="si22.svg"><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> compartment. On day <inline-formula><mml:math id="d1e787" display="inline" altimg="si23.svg"><mml:mi>k</mml:mi></mml:math></inline-formula>, individuals in the <inline-formula><mml:math id="d1e792" display="inline" altimg="si24.svg"><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> subgroup have a probability <inline-formula><mml:math id="d1e806" display="inline" altimg="si25.svg"><mml:msub><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> to be hospitalised and a complementary probability <inline-formula><mml:math id="d1e816" display="inline" altimg="si26.svg"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:msub><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> to move to the <inline-formula><mml:math id="d1e832" display="inline" altimg="si27.svg"><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> subgroup. As detailed in Appendix S2.5, two groups of hospitalised critical patients are considered. Upon hospitalisation, a proportion <inline-formula><mml:math id="d1e850" display="inline" altimg="si28.svg"><mml:msub><mml:mrow><mml:mi>ψ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> of them have a substantial chance, <inline-formula><mml:math id="d1e860" display="inline" altimg="si29.svg"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>, to recover and benefit from a long stay in an ICU; they are denoted by <inline-formula><mml:math id="d1e875" display="inline" altimg="si30.svg"><mml:msub><mml:mrow><mml:mi>H</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>⋅</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. Their length of stay is captured by probabilities <inline-formula><mml:math id="d1e890" display="inline" altimg="si31.svg"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>
(<inline-formula><mml:math id="d1e901" display="inline" altimg="si23.svg"><mml:mi>k</mml:mi></mml:math></inline-formula> denoting the number of days since hospitalisation) (<xref rid="b30" ref-type="bibr">Santé Publique France, 2020a</xref>). Those who will die, either after a short stay in ICU or in another ward, are denoted by <inline-formula><mml:math id="d1e912" display="inline" altimg="si33.svg"><mml:msub><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>⋅</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. Time to death for this latter compartment is captured by the sequence of <inline-formula><mml:math id="d1e926" display="inline" altimg="si34.svg"><mml:msub><mml:mrow><mml:mi>υ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>.</p>
              </sec>
              <sec id="sec2.2">
                <label>2.2</label>
                <title>Memory effects</title>
                <p id="d1e940">The daily probability for a key transition in the natural history of COVID-19 to occur is likely to increase with elapsed time. This has been documented for the onset of contagiousness and the respiratory complications, which are likely to arise in narrow time windows respectively around the 4th day since infection (<xref rid="b26" ref-type="bibr">Nishiura et al., 2020</xref>) and a week after symptom onset (<xref rid="b24" ref-type="bibr">Linton et al., 2020</xref>, <xref rid="b4" ref-type="bibr">Bouadma et al., 2020</xref>). To capture this ’ageing property’, which is lacking in the exponential distributions implicitly used by ODE models, we used Weibull distributions (<xref rid="b2" ref-type="bibr">Bolker, 2008</xref>) with shape parameters greater than <inline-formula><mml:math id="d1e959" display="inline" altimg="si4.svg"><mml:mn>1</mml:mn></mml:math></inline-formula> in the parameterisation of the time distributions involved in the model, as detailed in Appendix S2.6. For the sake of parsimony, we assume that these distributions are identically distributed across age classes.</p>
                <p id="d1e963">Importantly, our model does not require an incubation or a latency period to be specified explicitly. Instead, the contribution of each individual to the force of infection is weighted by the discretised empirical distribution of the serial interval estimated by <xref rid="b26" ref-type="bibr">Nishiura et al. (2020)</xref>, according to the age of its infection. This modelling approach eventually recovers a classical SIR model for the non-critical cases, capturing the empirical and effective non-homogeneous infectiousness period without recourse to additional arbitrary compartments (such as a latent/exposed <inline-formula><mml:math id="d1e970" display="inline" altimg="si36.svg"><mml:mi>E</mml:mi></mml:math></inline-formula>, and convalescent densities) and their corresponding parameters.</p>
                <p id="d1e974">
                  <fig id="fig2">
                    <label>Fig. 2</label>
                    <caption>
                      <p><bold>Predicted (plain line) and observed (dots) dynamics with (classical) memory-less processes.</bold> The continuous-time memory-less analog of the focal model poorly reproduces the observed trends in daily ICU admissions (turquoise triangles) and mortality (red circles) in France. Vertical lines indicate the beginning and end of the national lockdown.</p>
                    </caption>
                    <graphic xlink:href="gr2_lrg"/>
                  </fig>
                  <fig id="fig3">
                    <label>Fig. 3</label>
                    <caption>
                      <p><bold>Flow through time shape comparison between Markovian and non-Markovian dynamics.</bold> 100 individuals assumed to develop respiratory complications are infected the same day. The bars represent the number of daily ICU admissions related to this virtual cohort. Time between infection and admission follows either an exponential (in red) or a Weibull (in blue) distribution. Both distributions have the same mean, about 14.5 days. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p>
                    </caption>
                    <graphic xlink:href="gr3_lrg"/>
                  </fig>
                </p>
              </sec>
              <sec id="sec2.3">
                <label>2.3</label>
                <title>Data and estimation</title>
                <p id="d1e984">All statistical analyses and numerical integration were conducted in R (<xref rid="b27" ref-type="bibr">R Core Team, 2020</xref>). The system was initialized as a fully susceptible population according to the French population pyramid (<xref rid="b18" ref-type="bibr">Institut National de la Statistique et des Études Économiques, 2020</xref>) from which the residents of nursing homes (<xref rid="b25" ref-type="bibr">Muller, 2017</xref>) have been excluded, to focus on the general population viral circulation. Parameter inference was performed using nationwide daily ICU admissions, current ICU bed occupancy, as well as the cumulative number of deaths, all available on the French government data repository (<xref rid="b31" ref-type="bibr">Santé Publique France, 2020b</xref>). These time series were 7-day rolling averaged beforehand in order to correct for under-reporting during week-ends.</p>
                <p id="d1e1007">We first located the region of highest likelihood using initial parameter values estimated from data or compatible with the literature (see Appendix S1 for details). Then, the maximum likelihood estimates (MLE) and associated 95%-intervals were stepwise calculated (<xref rid="b3" ref-type="bibr">Bolker and Giné-Vázquez, 2020</xref>) with respect to daily ICU admissions, ICU discharges, and daily mortality time series, assuming a Gaussian noise around the prediction. The median and 95% confidence intervals of the model’s output are finally calculated as the daily sample quantiles across runs from 1000 randomly drawn parameter sets with statistically equivalent likelihoods (<xref rid="b35" ref-type="bibr">Wilks, 1938</xref>). Details on times series, parameter estimation and output calculations can be found in Appendix S2.4, S2.7, and S2.8 respectively. Moreover, we ran the fitting procedure using an alternative set of initial age-stratified IFRs (<xref rid="b29" ref-type="bibr">Salje et al. (2020)</xref> instead of <xref rid="b10" ref-type="bibr">Ferguson et al. (2020)</xref>) and show that our key estimates are robust to the uncertainty on this parameter (Appendix S3.2) .</p>
                <p id="d1e1029">
                  <fig id="fig4">
                    <label>Fig. 4</label>
                    <caption>
                      <p><bold>COVID-19 epidemic wave in France fitted by a non-Markovian discrete-time model.</bold><bold>Top panel.</bold> The blue and pink curves respectively represent the median daily ICU admissions and the median daily (hospital) mortality as generated by the fitted model. Turquoise triangles and red circles are the (rolling 7-day average) data counterparts. The black curve shows the median daily temporal reproduction number calculated from the simulated epidemic. The dotted horizontal line shows the reproduction number threshold value, i.e. <inline-formula><mml:math id="d1e73" display="inline" altimg="si4.svg"><mml:mn>1</mml:mn></mml:math></inline-formula>. <bold>Bottom panel.</bold> The blue and pink curves respectively represent the median number of occupied beds in ICU nationwide and the median cumulative (hospital) mortality as generated by the fitted model. The turquoise triangles and red circles are the (rolling 7-day average) data counterparts. The purple dotted horizontal line shows the initial French ICU capacity, ca. 5000 beds. The green curve shows the median proportion of the population that has recovered (and is assumed to be immune). The green dotted horizontal line corresponds to the median herd immunity threshold <inline-formula><mml:math id="d1e81" display="inline" altimg="si38.svg"><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:msubsup><mml:mrow><mml:mi mathvariant="script">R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:math></inline-formula>. The two vertical lines show respectively (from left to right) the beginning and the end of the French national lock-down. Shaded areas correspond to 95% confidence intervals. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p>
                    </caption>
                    <graphic xlink:href="gr4_lrg"/>
                  </fig>
                </p>
              </sec>
            </sec>
            <sec id="sec3">
              <label>3</label>
              <title>Results</title>
              <sec id="sec3.1">
                <label>3.1</label>
                <title>Memoryless approach</title>
                <p id="d1e1042">To illustrate the ability of our discrete model to capture COVID-19 short-term dynamics, we first explored the best outcome of parameter inference for a Markovian (memory-less) model.</p>
                <p id="d1e1044">As shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>, in spite of one additional degree of freedom compared to the focal model (see Appendix S2.9 for more details), the best fit performs poorly on the daily ICU admissions and mortality. Indeed, the model cannot capture both time series (respectively in blue and red). Furthermore, for each of the time series the decline phase after the lockdown (on Mar 17 for France) is underestimated. This can be explained by the fact that memoryless/Markovian models implicitly assume exponentially distributed waiting times that essentially cannot reproduce peaked dynamics, as shown by <xref rid="fig3" ref-type="fig">Fig. 3</xref>.</p>
                <p id="d1e1054">While this comparison shows that memory effects associated with contagiousness and critical symptom onset are essential to the epidemiological dynamics, preliminary fitting attempts have on the other hand shown that those associated with post-hospitalisation events (namely the distributions of <inline-formula><mml:math id="d1e1057" display="inline" altimg="si31.svg"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="d1e1067" display="inline" altimg="si34.svg"><mml:msub><mml:mrow><mml:mi>υ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) are weaker. Precisely, exponentially-distributed hospitalisation to ICU discharge or death intervals (namely <inline-formula><mml:math id="d1e1077" display="inline" altimg="si31.svg"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="d1e1088" display="inline" altimg="si34.svg"><mml:msub><mml:mrow><mml:mi>υ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) appear to be more parsimonious.</p>
                <p id="d1e1097">
                  <fig id="fig5">
                    <label>Fig. 5</label>
                    <caption>
                      <p><bold>Basic reproduction number, lock-down effect and initiation day estimates as a function of the date of censoring.</bold> Each dot represents the maximum likelihood estimate of the basic reproduction number <inline-formula><mml:math id="d1e111" display="inline" altimg="si43.svg"><mml:msub><mml:mrow><mml:mi mathvariant="script">R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> (top left), the lock-down effect <inline-formula><mml:math id="d1e121" display="inline" altimg="si44.svg"><mml:mi>κ</mml:mi></mml:math></inline-formula> (top right) and the initiation day <inline-formula><mml:math id="d1e126" display="inline" altimg="si45.svg"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> (top right) calculated from data truncated at the corresponding date on the <inline-formula><mml:math id="d1e137" display="inline" altimg="si46.svg"><mml:mi>x</mml:mi></mml:math></inline-formula>-axis. Bars shows 95% likelihood intervals.</p>
                    </caption>
                    <graphic xlink:href="gr5_lrg"/>
                  </fig>
                </p>
              </sec>
              <sec id="sec3.2">
                <label>3.2</label>
                <title>Epidemic parameter values estimation</title>
                <p id="d1e1105">Maximum likelihood estimates and 95% likelihood intervals (hereafter indicated by square brackets) were found for all parameters except those determining the generation time distribution (kept fixed following <xref rid="b26" ref-type="bibr">Nishiura et al., 2020</xref>). The basic reproduction number was estimated to 2.99 [2.59–3.39]. The effect of the lock-down is estimated to a 75.9% [72.9–78.7] reduction of the reproduction number. The estimates for the other parameters are all in line with official reports of average values. The epidemic wave is estimated to have started around Jan 20. This result is in agreement with early phylogenetic analyses on sequence data sampled in France (<xref rid="b6" ref-type="bibr">Danesh et al., 2020</xref>). Estimates and intervals for the other parameters are summarised in Table S-5.</p>
                <p id="d1e1116">The fitted non-Markovian discrete-time model accurately captures the dynamics of both the daily hospital mortality and the daily number of ICU admissions since most of the data points fall into the 95% confidence intervals. As can be observed in <xref rid="fig4" ref-type="fig">Fig. 4</xref>(top), the model correctly approaches the number of daily admissions in the vicinity of the peak, which is crucial for hospital management at both local and national levels.</p>
                <p id="d1e1122">We also present the temporal reproduction number (<inline-formula><mml:math id="d1e1126" display="inline" altimg="si47.svg"><mml:msub><mml:mrow><mml:mi mathvariant="script">R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>), which rapidly drops below unity following the onset of the national lock-down and was equal to 0.71 <inline-formula><mml:math id="d1e1136" display="inline" altimg="si48.svg"><mml:mfenced open="[" close="]"><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>69</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>74</mml:mn></mml:mrow></mml:mfenced></mml:math></inline-formula> by May 11 according to the model. Notice that <inline-formula><mml:math id="d1e1155" display="inline" altimg="si47.svg"><mml:msub><mml:mrow><mml:mi mathvariant="script">R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> started to decrease before the lock-down onset, due to density-dependent effects. In a model with strong host heterogeneity and so-called ‘super-spreaders’, this effect would be even more pronounced. Other explanations include local saturation, staggered implementation of pre-containment measures, such as health communication campaigns, or improved patient management as diagnosis and therapy became more effective. However, neither the structure of the model nor the level of detail in the available data makes it possible to identify the isolated impact of each measure on epidemiological dynamics.</p>
                <p id="d1e1164"><xref rid="fig4" ref-type="fig">Fig. 4</xref>(bottom) illustrates that the model also accurately captures the post-ICU admission dynamics (though with a slight tendency to overestimate the declining ICU bed occupancy), which is essential in assessing the risk of saturation of such hospital units, which would lead to excess-mortality. The fit to these data points could be improved with access to non-aggregated patient data or distributions of ICU residency time. The cumulative mortality curve is fitted with great accuracy, which allows us to use it as a comparison criterion between control strategies in further analyses. Finally, the figure also shows that the level of population immunisation, the median of which we estimate at 2.37% (<inline-formula><mml:math id="d1e1171" display="inline" altimg="si50.svg"><mml:mrow><mml:mfenced open="[" close="]"><mml:mrow><mml:mn>2</mml:mn><mml:mo>.</mml:mo><mml:mn>27</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>.</mml:mo><mml:mn>48</mml:mn></mml:mrow></mml:mfenced><mml:mtext>%</mml:mtext></mml:mrow></mml:math></inline-formula> 95%-CI) by May 11, is far below the classical group immunity threshold (<xref rid="b9" ref-type="bibr">ETE Modelling Team, 2020</xref>).</p>
              </sec>
              <sec id="sec3.3">
                <label>3.3</label>
                <title>Timing of the estimation</title>
                <p id="d1e1202">This model was applied to the early phase of the epidemic and its adequation to the data greatly improved on April 23, when French data on ICU residency time was made public. To illustrate the ability of the model to perform accurate parameter value estimations early in the epidemics, we performed the inference by censoring the data to the right.</p>
                <p id="d1e1204">As shown in <xref rid="fig5" ref-type="fig">Fig. 5</xref>, estimates with censoring on April 15, that is one month before the final data point shown in <xref rid="fig4" ref-type="fig">Fig. 4</xref>, were already accurate. Estimates with an earlier censoring are qualitatively correct but the confidence intervals larger. The enlargement of the last confidence intervals can be explained by a wider range of parameter sets having close likelihoods: either by fitting well the peak or the final slow decrease, possibly affected by improved care of hospitalised patients two months after the outbreak. As a supplementary result, we also provide in Appendix S3.3 the model forecast of the hospital time series based on the data available from Mar 18 to Apr 7 2020. With less than three weeks of daily figures, our framework was able to anticipate the following week trajectory and to capture the trend of the hospital dynamics for more than a month ahead.</p>
              </sec>
              <sec id="sec3.4">
                <label>3.4</label>
                <title>Response date impact</title>
                <p id="d1e1219">Using our estimated parameters, we then explored the effects of implementing the national lock-down a week earlier or a week later. As shown in <xref rid="fig6" ref-type="fig">Fig. 6</xref>, the peak was reached on Apr 8, with <inline-formula><mml:math id="d1e1226" display="inline" altimg="si51.svg"><mml:mrow><mml:mn>7019</mml:mn></mml:mrow></mml:math></inline-formula> ICU beds occupied (the model estimates it to Apr 12 and <inline-formula><mml:math id="d1e1232" display="inline" altimg="si52.svg"><mml:mrow><mml:mn>6920</mml:mn></mml:mrow></mml:math></inline-formula> beds). Enforcing the lock-down a week earlier (in green) would have led to an earlier and smaller epidemic peak with less than <inline-formula><mml:math id="d1e1239" display="inline" altimg="si53.svg"><mml:mrow><mml:mn>1500</mml:mn></mml:mrow></mml:math></inline-formula> ICU beds occupied on Apr 5. Conversely, another week of delay (in red) would have led to a peak above <inline-formula><mml:math id="d1e1245" display="inline" altimg="si54.svg"><mml:mrow><mml:mn>32</mml:mn><mml:mspace width="0.16667em"/><mml:mn>000</mml:mn></mml:mrow></mml:math></inline-formula> beds occupied in ICU on Apr 18, which is largely above the ICU capacity at the time (ca. <inline-formula><mml:math id="d1e1254" display="inline" altimg="si55.svg"><mml:mrow><mml:mn>5000</mml:mn></mml:mrow></mml:math></inline-formula> beds). Overall, in the range studied, each elapsed week multiplies ICU occupancy peak by more than 4.5, while delaying it by 3 weeks.</p>
                <p id="d1e1259">
These differences also translate in terms of mortality. According to the model, implementing the lock-down a week earlier could have led to <inline-formula><mml:math id="d1e1266" display="inline" altimg="si56.svg"><mml:mrow><mml:mn>13</mml:mn><mml:mspace width="0.16667em"/><mml:mn>300</mml:mn></mml:mrow></mml:math></inline-formula> [<inline-formula><mml:math id="d1e1275" display="inline" altimg="si57.svg"><mml:mrow><mml:mn>12</mml:mn><mml:mspace width="0.16667em"/><mml:mn>900</mml:mn></mml:mrow></mml:math></inline-formula>–<inline-formula><mml:math id="d1e1285" display="inline" altimg="si58.svg"><mml:mrow><mml:mn>13</mml:mn><mml:mspace width="0.16667em"/><mml:mn>700</mml:mn></mml:mrow></mml:math></inline-formula>] less deaths, while waiting for an additional week could have claimed <inline-formula><mml:math id="d1e1294" display="inline" altimg="si59.svg"><mml:mrow><mml:mn>52</mml:mn><mml:mspace width="0.16667em"/><mml:mn>800</mml:mn></mml:mrow></mml:math></inline-formula> [<inline-formula><mml:math id="d1e1303" display="inline" altimg="si60.svg"><mml:mrow><mml:mn>45</mml:mn><mml:mspace width="0.16667em"/><mml:mn>800</mml:mn></mml:mrow></mml:math></inline-formula>–<inline-formula><mml:math id="d1e1312" display="inline" altimg="si61.svg"><mml:mrow><mml:mn>61</mml:mn><mml:mspace width="0.16667em"/><mml:mn>500</mml:mn></mml:mrow></mml:math></inline-formula>] more lives (<xref rid="fig7" ref-type="fig">Fig. 7</xref>).<fig id="fig6"><label>Fig. 6</label><caption><p><bold>Lock-down implementation date effect and ICU bed occupancy.</bold> Each curve represents the median current ICU bed occupancy as generated by the model according to a given lock-down scenario, while their surrounding shaded areas correspond to their 95% confidence intervals. From bottom to top: the green scenario simulates an early national lock-down (on March 10th); the purple scenario is the realised one (lock-down beginning on Mar 17); the pink scenario simulates a late lock-down (on Mar 24th). Vertical lines indicate lock-down implementation dates. Crosses indicate the median ICU peak activity. Triangles represent the data and the dotted line the maximum ICU bed capacity in France. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p></caption><graphic xlink:href="gr6_lrg"/></fig><fig id="fig7"><label>Fig. 7</label><caption><p><bold>Estimated lock-down date effect on cumulative mortality.</bold> Each curve represents the median cumulative (hospital) mortality as generated by the model according to a given lock-down scenario, while their surrounding shaded areas correspond the their 95% confidence intervals. The scenarios are as detailed in <xref rid="fig6" ref-type="fig">Fig. 6</xref>. Dots represent the data.</p></caption><graphic xlink:href="gr7_lrg"/></fig></p>
              </sec>
            </sec>
            <sec id="sec4">
              <label>4</label>
              <title>Discussion</title>
              <p id="d1e1331">COVID-19 is not an unusually lethal or contagious infectious disease. On the other hand, the large proportion of transmission attributable to individuals with few or no symptoms makes it redoubtably difficult to control compared to e.g. SARS (<xref rid="b14" ref-type="bibr">Fraser et al., 2004</xref>). In the absence of a massive and homogeneous screening effort, the dynamics of COVID-19 can only be studied through hospitalisations induced by complications, which are rare and occur on average two weeks after infection. The marginal, indirect, and delayed nature of these events justifies the use of statistical analyses and mathematical modelling in the short-term epidemiological management of this unprecedented health crisis. However, given the magnitude of the risks at stake, the diversity of fields involved, and the number of unknowns (such as climate effects, immunity duration), mathematical modelling predictions should be handled with caution in the decision process.</p>
              <p id="d1e1338">Informing decision-making processes is challenging because most mathematical modelling in epidemiology relies on ordinary differential equations. These offer a wide palette of analytical tools, but they also become less accurate on short time scales. Conversely, stochastic models, whether agent-based or not, offer a much more precise picture of the early stages of the epidemics. However, they become less necessary once the outbreak threshold has been crossed and epidemic dynamics become essentially deterministic.</p>
              <p id="d1e1340">We therefore developed an original framework at the crossroads of individual-centred and compartmental modelling approaches, tailored to the COVID-19 natural history, which has two great advantages. First, its discrete time structure, shared with that of common epidemiological data, allows us to assume any distribution for model processes, therefore introducing what is known in the literature as memory effects (or ‘non-Markovian’ processes), related to the age of the infection. As a result, we obtain a much better fit than classical memory-less (or ‘Markovian’) models on intermediate timescales (weeks or months). Second, the deterministic nature of the model allows us to perform extremely fast simulations, especially compared to agent-based modelling that requires the drawing of millions of random numbers for a single simulation. The computational performance combined with the great parsimony, that still allows it to accurately fit the observed epidemiological dynamics, makes this model a relevant tool that can be easily transposed and deployed to other settings, countries or scales, even with solely aggregated publicly available data — as it is the case in the present work, while the extension to age-stratified data sets is straightforward.</p>
              <p id="d1e1342">First, we used our model to infer three key parameters of the epidemics. Our estimate of <inline-formula><mml:math id="d1e1345" display="inline" altimg="si43.svg"><mml:msub><mml:mrow><mml:mi mathvariant="script">R</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is comparable to that already computed in France based on their 95% confidence interval (<xref rid="b7" ref-type="bibr">Di Domenico et al., 2020</xref>, <xref rid="b29" ref-type="bibr">Salje et al., 2020</xref>). We also estimate the temporal reproduction number <inline-formula><mml:math id="d1e1360" display="inline" altimg="si47.svg"><mml:msub><mml:mrow><mml:mi mathvariant="script">R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> after the lock-down to 0.71, in line with the estimates of other studies (<xref rid="b29" ref-type="bibr">Salje et al., 2020</xref>, <xref rid="b17" ref-type="bibr">Hoertel et al., 2020</xref>, <xref rid="b13" ref-type="bibr">Forien et al., 2020</xref>), and the number of lives potentially saved (more than <inline-formula><mml:math id="d1e1376" display="inline" altimg="si64.svg"><mml:mrow><mml:mn>50</mml:mn><mml:mspace width="0.16667em"/><mml:mn>000</mml:mn></mml:mrow></mml:math></inline-formula>) compared to a lock-down implemented a week later.</p>
              <p id="d1e1384">The model makes several strong assumptions, the strongest being the mean-field approximation: the population is supposed to be well-mixed. This limitation can become strong if the epidemic grows in size to infect a large proportion of the population. Nonetheless, earlier works have shown that non spatially structured models produce conservative estimates from a public health viewpoint, while their parsimony and tractability outweighs the greater precision provided by finer models (<xref rid="b19" ref-type="bibr">Keeling, 1999</xref>, <xref rid="b32" ref-type="bibr">Trapman et al., 2016</xref>). Second, there is no specification of the public health control measures implemented: all the options (quarantine of confirmed cases, adoption of barrier measures, social distancing: closing of schools and universities, banning of gatherings, etc.) are combined to reduce the contact rate. We also neglected fomite transmission (see <xref rid="b11" ref-type="bibr">Ferretti et al., 2020</xref> for an example) and assumed perfect and lifelong immunity against reinfection due to currently insufficient data on immunity. One simplifying assumption we made is that mortality probabilities do not vary over time, whereas in practice hospital saturation could affect mortality, whether related to COVID-19 or not.</p>
              <p id="d1e1395">In terms of outlook, the model can straightforwardly be extended to formally take into account any kind of finer stratification, e.g. age, sex, and comorbidities simultaneously and take advantage of a discrete implicit spatial structure. This work has laid the foundation for two epidemic surveillance and projection online applications, respectively at the national (<xref rid="b28" ref-type="bibr">Reyné et al., 2020</xref>) (published in Jul 2020) and infra-national level (<xref rid="b1" ref-type="bibr">Boennec et al., 2021</xref>) (published in Feb 2021 and currently referenced by the French government data and app repository). Future work includes taking into account possible changes in parameter values with time, mainly detecting and estimating seasonal effects. If these are of significant impact, model fitting could be adapted, either by estimating parameters within defined time windows or by left-censoring the data as time goes by. Beyond the ongoing pandemic, this framework can be easily adapted and deployed as a now- and forecasting tool in future outbreaks.</p>
            </sec>
            <sec id="d1e1407">
              <title>CRediT authorship contribution statement</title>
              <p id="d1e1410"><bold>Mircea T. Sofonea:</bold> Conceptualization, Methodology, Software, Formal analysis, Investigation, Visualization, Writing - original draft, Validation. <bold>Bastien Reyné:</bold> Data curation, Software, Validation. <bold>Baptiste Elie:</bold> Data curation, Validation. <bold>Ramsès Djidjou-Demasse:</bold> Resources, Writing - review &amp; editing, Validation. <bold>Christian Selinger:</bold> Resources, Writing - review &amp; editing, Validation. <bold>Yannis Michalakis:</bold> Writing - original draft, Validation. <bold>Samuel Alizon:</bold> Writing - original draft, Supervision, Validation.</p>
            </sec>
            <sec sec-type="COI-statement">
              <title>Declaration of Competing Interest</title>
              <p id="d1e1436">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>
            </sec>
          </body>
          <back>
            <ref-list id="bib1">
              <title>References</title>
              <ref id="b1">
                <element-citation publication-type="book" id="sb1">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boennec</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Alizon</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sofonea</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <collab>ETE Modelling Team</collab>
                  </person-group>
                  <chapter-title>COVIDici</chapter-title>
                  <year>2021</year>
                  <comment>covid-ete.ouvaton.org; Available from: <ext-link ext-link-type="uri" xlink:href="https://cloudapps.france-bioinformatique.fr/covidici/" id="interref2">https://cloudapps.france-bioinformatique.fr/covidici/</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b2">
                <element-citation publication-type="book" id="sb2">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bolker</surname>
                      <given-names>B.M.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Ecological Models and Data in R</chapter-title>
                  <year>2008</year>
                  <publisher-name>Princeton University Press</publisher-name>
                  <publisher-loc>Princeton, NJ</publisher-loc>
                </element-citation>
              </ref>
              <ref id="b3">
                <element-citation publication-type="book" id="sb3">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bolker</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Giné-Vázquez</surname>
                      <given-names>I.</given-names>
                    </name>
                    <collab>R Development Core Team</collab>
                  </person-group>
                  <chapter-title>Bbmle: Tools for general maximum likelihood estimation. R package version 1.0.23.1</chapter-title>
                  <year>2020</year>
                </element-citation>
              </ref>
              <ref id="b4">
                <element-citation publication-type="journal" id="sb4">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bouadma</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Lescure</surname>
                      <given-names>F.X.</given-names>
                    </name>
                    <name>
                      <surname>Lucet</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Yazdanpanah</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Timsit</surname>
                      <given-names>J.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists</article-title>
                  <source>Intensive Care Med.</source>
                  <volume>46</volume>
                  <issue>4</issue>
                  <year>2020</year>
                  <fpage>579</fpage>
                  <lpage>582</lpage>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://link.springer.com/10.1007/s00134-020-05967-x" id="interref3">http://link.springer.com/10.1007/s00134-020-05967-x</ext-link></comment>
                  <pub-id pub-id-type="pmid">32103284</pub-id>
                </element-citation>
              </ref>
              <ref id="b5">
                <element-citation publication-type="journal" id="sb5">
                  <person-group person-group-type="author">
                    <collab>Coronaviridae Study Group of the ICTV</collab>
                  </person-group>
                  <article-title>The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2</article-title>
                  <source>Nat. Microbiol.</source>
                  <year>2020</year>
                  <fpage>1</fpage>
                  <lpage>9</lpage>
                  <comment>
                    <ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/s41564-020-0695-z" id="interref4">https://www.nature.com/articles/s41564-020-0695-z</ext-link>
                  </comment>
                  <pub-id pub-id-type="pmid">31857732</pub-id>
                </element-citation>
              </ref>
              <ref id="b6">
                <element-citation publication-type="book" id="sb6">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Danesh</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Elie</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Alizon</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Early phylodynamics analysis of the COVID-19 epidemics in France using 194 genomes</chapter-title>
                  <year>2020</year>
                  <comment>virological.org; Available from: <ext-link ext-link-type="uri" xlink:href="http://virological.org/t/early-phylodynamics-analysis-of-the-covid-19-epidemics-in-france-using-194-genomes-april-10-2020/467" id="interref5">http://virological.org/t/early-phylodynamics-analysis-of-the-covid-19-epidemics-in-france-using-194-genomes-april-10-2020/467</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b7">
                <element-citation publication-type="journal" id="sb7">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Di Domenico</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Pullano</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Sabbatini</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <name>
                      <surname>Boëlle</surname>
                      <given-names>P.Y.</given-names>
                    </name>
                    <name>
                      <surname>Colizza</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Expected impact of lockdown in Île-de-France and possible exit strategies</article-title>
                  <source>Inf. Dis. (except HIV/AIDS)</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://medrxiv.org/lookup/doi/10.1101/2020.04.13.20063933" id="interref6">http://medrxiv.org/lookup/doi/10.1101/2020.04.13.20063933</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b8">
                <element-citation publication-type="journal" id="sb8">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Djidjou-Demasse</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Michalakis</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Choisy</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Sofonea</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Alizon</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Optimal COVID-19 epidemic control until vaccine deployment</article-title>
                  <source>Inf. Dis. (except HIV/AIDS)</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://medrxiv.org/lookup/doi/10.1101/2020.04.02.20049189" id="interref7">http://medrxiv.org/lookup/doi/10.1101/2020.04.02.20049189</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b9">
                <element-citation publication-type="book" id="sb9">
                  <person-group person-group-type="author">
                    <collab>ETE Modelling Team</collab>
                  </person-group>
                  <chapter-title>Herd immunity &amp; epidemic final size</chapter-title>
                  <year>2020</year>
                  <comment>covid-ete.ouvaton.org; Available from: <ext-link ext-link-type="uri" xlink:href="http://covid-ete.ouvaton.org/Report2_Immunization.html" id="interref8">http://covid-ete.ouvaton.org/Report2_Immunization.html</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b10">
                <element-citation publication-type="book" id="sb10">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ferguson</surname>
                      <given-names>N.M.</given-names>
                    </name>
                    <name>
                      <surname>Laydon</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Nedjati-Gilani</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Imai</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Ainslie</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Baguelin</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand</chapter-title>
                  <year>2020</year>
                  <comment>imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/covid-19-reports/; Available from: <ext-link ext-link-type="uri" xlink:href="http://hdl.handle.net/10044/1/77482" id="interref9">http://hdl.handle.net/10044/1/77482</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b11">
                <element-citation publication-type="journal" id="sb11">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ferretti</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Wymant</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Kendall</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Nurtay</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bonsall</surname>
                      <given-names>D.G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Quantifying dynamics of SARS-CoV-2 transmission suggests that epidemic control and avoidance is feasible through instantaneous digital contact tracing</article-title>
                  <source>medRxiv</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.03.08.20032946v1" id="interref10">https://www.medrxiv.org/content/10.1101/2020.03.08.20032946v1</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b12">
                <element-citation publication-type="journal" id="sb12">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Flaxman</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Mishra</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Gandy</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Unwin</surname>
                      <given-names>H.J.T.</given-names>
                    </name>
                    <name>
                      <surname>Mellan</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Coupland</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe</article-title>
                  <source>Nature.</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/s41586-020-2405-7" id="interref11">https://www.nature.com/articles/s41586-020-2405-7</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b13">
                <element-citation publication-type="journal" id="sb13">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Forien</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Pang</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Pardoux</surname>
                      <given-names>É.</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimating the state of the Covid-19 epidemic in France using a non-Markovian model</article-title>
                  <source>medRxiv.</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.06.27.20141671v2" id="interref12">https://www.medrxiv.org/content/10.1101/2020.06.27.20141671v2</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b14">
                <element-citation publication-type="journal" id="sb14">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fraser</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Riley</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Ferguson</surname>
                      <given-names>N.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Factors that make an infectious disease outbreak controllable</article-title>
                  <source>Proc. Natl. Acad. Sci.</source>
                  <volume>101</volume>
                  <issue>16</issue>
                  <year>2004</year>
                  <fpage>6146</fpage>
                  <lpage>6151</lpage>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.pnas.org/cgi/doi/10.1073/pnas.0307506101" id="interref13">http://www.pnas.org/cgi/doi/10.1073/pnas.0307506101</ext-link></comment>
                  <pub-id pub-id-type="pmid">15071187</pub-id>
                </element-citation>
              </ref>
              <ref id="b15">
                <element-citation publication-type="journal" id="sb15">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Halpern</surname>
                      <given-names>S.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>ICU capacity strain and the quality and allocation of critical care</article-title>
                  <source>Curr. Opin. Crit. Care</source>
                  <volume>17</volume>
                  <issue>6</issue>
                  <year>2011</year>
                  <fpage>648</fpage>
                  <lpage>657</lpage>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://journals.lww.com/co-criticalcare/Abstract/2011/1200/ICU_capacity_strain_and_the_quality_and_allocation.18.aspx" id="interref14">https://journals.lww.com/co-criticalcare/Abstract/2011/1200/ICU_capacity_strain_and_the_quality_and_allocation.18.aspx</ext-link></comment>
                  <pub-id pub-id-type="pmid">21986461</pub-id>
                </element-citation>
              </ref>
              <ref id="b16">
                <element-citation publication-type="journal" id="sb16">
                  <person-group person-group-type="author">
                    <name>
                      <surname>He</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Lau</surname>
                      <given-names>E.H.Y.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hao</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Temporal dynamics in viral shedding and transmissibility of COVID-19</article-title>
                  <source>Nat. Med.</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/articles/s41591-020-0869-5" id="interref15">http://www.nature.com/articles/s41591-020-0869-5</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b17">
                <element-citation publication-type="journal" id="sb17">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hoertel</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Blachier</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Blanco</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Olfson</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Massetti</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rico</surname>
                      <given-names>M.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in France</article-title>
                  <source>medRxiv.</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.04.30.20086264v1" id="interref16">https://www.medrxiv.org/content/10.1101/2020.04.30.20086264v1</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b18">
                <element-citation publication-type="book" id="sb18">
                  <person-group person-group-type="author">
                    <collab>Institut National de la Statistique et des Études Économiques</collab>
                  </person-group>
                  <chapter-title>Pyramide des âges 2020 - France et France métropolitaine. insee.fr</chapter-title>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.insee.fr/fr/statistiques/3312958" id="interref17">https://www.insee.fr/fr/statistiques/3312958</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b19">
                <element-citation publication-type="journal" id="sb19">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Keeling</surname>
                      <given-names>M.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The effects of local spatial structure on epidemiological invasions</article-title>
                  <source>Proc. R. Soc. Lond. B</source>
                  <volume>266</volume>
                  <issue>1421</issue>
                  <year>1999</year>
                  <fpage>859</fpage>
                  <lpage>867</lpage>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://royalsocietypublishing.org/doi/abs/10.1098/rspb.1999.0716" id="interref18">https://royalsocietypublishing.org/doi/abs/10.1098/rspb.1999.0716</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b20">
                <element-citation publication-type="book" id="sb20">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Keeling</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Rohani</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Modeling Infectious Diseases in Humans and Animals</chapter-title>
                  <year>2008</year>
                  <publisher-name>Princeton University Press</publisher-name>
                </element-citation>
              </ref>
              <ref id="b21">
                <element-citation publication-type="journal" id="sb21">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kermack</surname>
                      <given-names>W.O.</given-names>
                    </name>
                    <name>
                      <surname>McKendrick</surname>
                      <given-names>A.G.</given-names>
                    </name>
                  </person-group>
                  <article-title>A contribution to the mathematical theory of epidemics</article-title>
                  <source>Proc. R Soc. Lond. A.</source>
                  <volume>115</volume>
                  <year>1927</year>
                  <fpage>700</fpage>
                  <lpage>721</lpage>
                </element-citation>
              </ref>
              <ref id="b22">
                <element-citation publication-type="journal" id="sb22">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Guan</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Tong</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus - infected pneumonia</article-title>
                  <source>N. Engl. J. Med.</source>
                  <volume>382</volume>
                  <issue>13</issue>
                  <year>2020</year>
                  <fpage>1199</fpage>
                  <lpage>1207</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id>
                  <pub-id pub-id-type="pmid">31995857</pub-id>
                </element-citation>
              </ref>
              <ref id="b23">
                <element-citation publication-type="journal" id="sb23">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Pei</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)</article-title>
                  <source>Science</source>
                  <volume>368</volume>
                  <issue>6490</issue>
                  <year>2020</year>
                  <fpage>489</fpage>
                  <lpage>493</lpage>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://science.sciencemag.org/content/368/6490/489" id="interref19">https://science.sciencemag.org/content/368/6490/489</ext-link></comment>
                  <pub-id pub-id-type="pmid">32179701</pub-id>
                </element-citation>
              </ref>
              <ref id="b24">
                <element-citation publication-type="journal" id="sb24">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Linton</surname>
                      <given-names>N.M.</given-names>
                    </name>
                    <name>
                      <surname>Kobayashi</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Hayashi</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Akhmetzhanov</surname>
                      <given-names>A.R.</given-names>
                    </name>
                    <name>
                      <surname>Jung</surname>
                      <given-names>Sm</given-names>
                    </name>
                  </person-group>
                  <article-title>Novel coronavirus infections with right truncation: A statistical analysis of publicly available case data</article-title>
                  <source>J. Clin. Med.</source>
                  <volume>9</volume>
                  <issue>2</issue>
                  <year>2020</year>
                  <fpage>538</fpage>
                  <comment>
                    <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/2077-0383/9/2/538" id="interref20">https://www.mdpi.com/2077-0383/9/2/538</ext-link>
                  </comment>
                </element-citation>
              </ref>
              <ref id="b25">
                <element-citation publication-type="book" id="sb25">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muller</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <chapter-title>Drees. 728 000 résidents en établissements d’hébergement pour personnes âgées en 2015 (Études et Résultats, n.1015, DREES)</chapter-title>
                  <year>2017</year>
                  <comment>drees.solidarites-sante.gouv.fr; Available from: <ext-link ext-link-type="uri" xlink:href="http://drees.solidarites-sante.gouv.fr/etudes-et-statistiques/publications/etudes-et-resultats/article/728-000-residents-en-etablissements-d-hebergement-pour-personnes-agees-en-2015" id="interref21">http://drees.solidarites-sante.gouv.fr/etudes-et-statistiques/publications/etudes-et-resultats/article/728-000-residents-en-etablissements-d-hebergement-pour-personnes-agees-en-2015</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b26">
                <element-citation publication-type="journal" id="sb26">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nishiura</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Linton</surname>
                      <given-names>N.M.</given-names>
                    </name>
                    <name>
                      <surname>Akhmetzhanov</surname>
                      <given-names>A.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Serial interval of novel coronavirus (COVID-19) infections</article-title>
                  <source>Int. J. Infect. Dis.</source>
                  <volume>93</volume>
                  <year>2020</year>
                  <fpage>284</fpage>
                  <lpage>286</lpage>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1201971220301193" id="interref22">https://linkinghub.elsevier.com/retrieve/pii/S1201971220301193</ext-link></comment>
                  <pub-id pub-id-type="pmid">32145466</pub-id>
                </element-citation>
              </ref>
              <ref id="b27">
                <element-citation publication-type="book" id="sb27">
                  <person-group person-group-type="author">
                    <collab>R Core Team</collab>
                  </person-group>
                  <chapter-title>R: A Language and Environment for Statistical Computing</chapter-title>
                  <year>2020</year>
                  <publisher-name>R Foundation for Statistical Computing</publisher-name>
                  <publisher-loc>Vienna, Austria</publisher-loc>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org" id="interref23">https://www.R-project.org</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b28">
                <element-citation publication-type="book" id="sb28">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reyné</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Alizon</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sofonea</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <collab>ETE Modelling Team</collab>
                  </person-group>
                  <chapter-title>COVIDSIM-2</chapter-title>
                  <year>2020</year>
                  <comment>covid-ete.ouvaton.org; Available from: <ext-link ext-link-type="uri" xlink:href="https://bioinfo-shiny.ird.fr/COVIDSIM2-fr/" id="interref24">https://bioinfo-shiny.ird.fr/COVIDSIM2-fr/</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b29">
                <element-citation publication-type="journal" id="sb29">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Salje</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Kiem</surname>
                      <given-names>C.T.</given-names>
                    </name>
                    <name>
                      <surname>Lefrancq</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Courtejoie</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Bosetti</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Paireau</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimating the burden of SARS-CoV-2 in France</article-title>
                  <source>Science.</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://science.sciencemag.org/content/early/2020/05/12/science.abc3517" id="interref25">https://science.sciencemag.org/content/early/2020/05/12/science.abc3517</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b30">
                <element-citation publication-type="book" id="sb30">
                  <person-group person-group-type="author">
                    <collab>Santé Publique France</collab>
                  </person-group>
                  <chapter-title>COVID-19 : Point épidémiologique hebdomadaire du 7 mai 2020</chapter-title>
                  <year>2020</year>
                  <comment>santepubliquefrance.fr; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.santepubliquefrance.fr/content/download/250807/2596023" id="interref26">https://www.santepubliquefrance.fr/content/download/250807/2596023</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b31">
                <element-citation publication-type="book" id="sb31">
                  <person-group person-group-type="author">
                    <collab>Santé Publique France</collab>
                  </person-group>
                  <chapter-title>Données hospitalières relatives à l’épidémie de COVID-19</chapter-title>
                  <year>2020</year>
                  <comment>data.gouv.fr; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.data.gouv.fr/fr/datasets/donnees-hospitalieres-relatives-a-lepidemie-de-covid-19/" id="interref27">https://www.data.gouv.fr/fr/datasets/donnees-hospitalieres-relatives-a-lepidemie-de-covid-19/</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b32">
                <element-citation publication-type="journal" id="sb32">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Trapman</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Ball</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Dhersin</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Tran</surname>
                      <given-names>V.C.</given-names>
                    </name>
                    <name>
                      <surname>Wallinga</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Britton</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Inferring <italic>R</italic><inline-formula><mml:math id="d1e2881" display="inline" altimg="si65.svg"><mml:msub><mml:mrow/><mml:mrow><mml:mtext>0</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula> in emerging epidemics—the effect of common population structure is small</article-title>
                  <source>J. R. Soc. Interface</source>
                  <volume>13</volume>
                  <issue>121</issue>
                  <year>2016</year>
                  <object-id pub-id-type="publisher-id">20160288</object-id>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://royalsocietypublishing.org/doi/10.1098/rsif.2016.0288" id="interref28">https://royalsocietypublishing.org/doi/10.1098/rsif.2016.0288</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b33">
                <element-citation publication-type="journal" id="sb33">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Verity</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Okell</surname>
                      <given-names>L.C.</given-names>
                    </name>
                    <name>
                      <surname>Dorigatti</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Winskill</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Whittaker</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Imai</surname>
                      <given-names>N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimates of the severity of coronavirus disease 2019: a model-based analysis</article-title>
                  <source>Lancet Infect. Dis.</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2820%2930243-7/abstract" id="interref29">https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30243-7/abstract</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b34">
                <element-citation publication-type="journal" id="sb34">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Weissman</surname>
                      <given-names>G.E.</given-names>
                    </name>
                    <name>
                      <surname>Crane-Droesch</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Chivers</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Luong</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hanish</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Levy</surname>
                      <given-names>M.Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Locally informed simulation to predict hospital capacity needs during the COVID-19 pandemic</article-title>
                  <source>Ann. Int. Med.</source>
                  <year>2020</year>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.acpjournals.org/doi/full/10.7326/M20-1260" id="interref30">https://www.acpjournals.org/doi/full/10.7326/M20-1260</ext-link></comment>
                </element-citation>
              </ref>
              <ref id="b35">
                <element-citation publication-type="journal" id="sb35">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wilks</surname>
                      <given-names>S.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>The large-sample distribution of the likelihood ratio for testing composite hypotheses</article-title>
                  <source>Ann. Math. Stat.</source>
                  <volume>9</volume>
                  <issue>1</issue>
                  <year>1938</year>
                  <fpage>60</fpage>
                  <lpage>62</lpage>
                  <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.jstor.org/stable/2957648" id="interref31">https://www.jstor.org/stable/2957648</ext-link></comment>
                </element-citation>
              </ref>
            </ref-list>
            <sec id="appSB" sec-type="supplementary-material">
              <label>Appendix A</label>
              <title>Mathematical notations, model details and supplementary results</title>
              <p id="d1e1478">The following is the Supplementary material related to this article. <supplementary-material content-type="local-data" id="mmc1"><caption><title>MMC S1</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material>
</p>
            </sec>
            <ack id="d1e1438">
              <title>Acknowledgements</title>
              <p id="d1e1441">We acknowledge funding from <funding-source id="GS1">Région Occitanie and the ANR</funding-source> (PHYEPI grant). We also acknowledge logistical support from the <funding-source id="GS2"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100008222</institution-id><institution>University of Montpellier</institution></institution-wrap></funding-source>, the <funding-source id="GS3"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100004794</institution-id><institution>CNRS</institution></institution-wrap></funding-source> and the <funding-source id="GS4"><institution-wrap><institution-id institution-id-type="doi">10.13039/100012947</institution-id><institution>IRD</institution></institution-wrap></funding-source> (especially its South Green computational platform), and the <funding-source id="GS5">French Institute of Bioinformatics</funding-source>
.</p>
            </ack>
            <fn-group>
              <fn id="appSA" fn-type="supplementary-material">
                <label>Appendix A</label>
                <p id="d1e1468">Supplementary material related to this article can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.epidem.2021.100459" id="interref1">https://doi.org/10.1016/j.epidem.2021.100459</ext-link>.</p>
              </fn>
            </fn-group>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
